Biotech Outsourcing Strategies (BOS) Basel 2025

About Biotech Outsourcing Strategies Basel 2025

Join Thermo Fisher Scientific at Biotech Outsourcing Strategies (BOS) Basel 2025, a premier event designed to facilitate R&D outsourcing in the biotech sector. This 2-day event focuses on fostering connections across the drug development continuum—particularly in development-stage biotechs focused on small molecules and biologics.

Early development is critical for oral solid dose (OSD) therapies. Making the right decisions at this stage can significantly impact speed, cost, and long-term commercial success. We’re thrilled to showcase Accelerator™ Drug Development service offering—designed to streamline and accelerate the early development of OSD programs.

With the Accelerator Drug Development, we help reduce timelines and minimize risk through customized formulation strategies, integrated API–OSD services, and a global network of development and manufacturing sites. Accelerator Drug Development provides the connected expertise, foresight, and unparalleled resources needed to drive success at every stage of your drug development.

As your trusted partner in drug development, our goal is to bring your therapeutic innovations to patients as quickly and efficiently as possible.

Discover our OSD services at BOS Basel 2025.